Neurocrine Biosciences Inc (NBIX) financials · P/E 20, rev $2.86B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Neurocrine Biosciences Inc (NBIX) P/E 20, rev $2.86B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $2.86B | $2.36B |
| Cost of Revenue | $52.1M | $34.0M |
| Gross Profit | $2.81B | $2.32B |
| Operating Income | $619.1M | $570.5M |
| Net Income | $478.6M | $341.3M |
| EPS (Diluted) | $4.67 | $3.29 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $4.63B | $3.72B |
| Current Assets | $2.52B | $1.72B |
| Cash & Equivalents | $713.0M | $233.0M |
| Inventory | $69.0M | $57.4M |
| PP&E | $89.8M | $82.6M |
| Total Liabilities | $1.38B | $1.13B |
| Current Liabilities | $743.4M | $507.7M |
| Shareholders' Equity | $3.25B | $2.59B |
| Retained Earnings | $447.7M | $29.2M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $782.7M | $595.4M |
| CapEx | $34.0M | $38.2M |
| Investing Cash Flow | -$264.4M | -$126.8M |
| Financing Cash Flow | -$38.3M | -$486.7M |
| Net Change in Cash | $480.0M | -$18.1M |
| Free Cash Flow | $748.7M | $557.2M |
FAQ
What is NBIX P/E and revenue?
Neurocrine Biosciences Inc (NBIX) P/E 20, rev $2.86B.
What is NBIX revenue?
Neurocrine Biosciences Inc last cached revenue is $2.86B (FY2025).
Is NBIX profitable?
Neurocrine Biosciences Inc last cached net income is $478.6M (FY2025).
What are NBIX total assets?
Neurocrine Biosciences Inc last cached total assets are $4.63B (FY2025).
What is NBIX free cash flow?
Neurocrine Biosciences Inc last cached free cash flow is $748.7M (FY2025).
Not investment advice. Cached statements, not a live tape.